MLi-2 Kinase Inhibitor Fully Restores Neuronal Cilia and Promotes Recovery in a Parkinson’s Mouse Model

The preclinical success supports multiple ongoing LRRK2 inhibitor trials, suggesting that the approach could extend to non-genetic Parkinson’s.